PPBT PE Ratio & Valuation,Is PPBT Overvalued

PPBT Relative Valuation

PPBT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PPBT is overvalued; if below, it's undervalued.

Historical Valuation

Purple Biotech Ltd (PPBT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -6.46. The fair price of Purple Biotech Ltd (PPBT) is between -- to -- according to relative valuation methord.

Relative Value

Fair Zone

-----

Current Price：0.75

Fair

-0.44

0.00

EV/EBITDA

Purple Biotech Ltd. (PPBT) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

0.38

EV/EBIT

Purple Biotech Ltd. (PPBT) has a current EV/EBIT of 0.38. The 5-year average EV/EBIT is -0.75. The thresholds are as follows: Strongly Undervalued below -2.99, Undervalued between -2.99 and -1.87, Fairly Valued between 0.37 and -1.87, Overvalued between 0.37 and 1.50, and Strongly Overvalued above 1.50. The current Forward EV/EBIT of 0.38 falls within the Overvalued range.

0.00

Purple Biotech Ltd. (PPBT) has a current PS of 0.00. The 5-year average PS is 1.64. The thresholds are as follows: Strongly Undervalued below -4.78, Undervalued between -4.78 and -1.57, Fairly Valued between 4.85 and -1.57, Overvalued between 4.85 and 8.06, and Strongly Overvalued above 8.06. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Purple Biotech Ltd. (PPBT) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.64. The thresholds are as follows: Strongly Undervalued below -5.75, Undervalued between -5.75 and -2.55, Fairly Valued between 3.83 and -2.55, Overvalued between 3.83 and 7.03, and Strongly Overvalued above 7.03. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-0.63

P/FCF

Purple Biotech Ltd. (PPBT) has a current P/FCF of -0.63. The 5-year average P/FCF is -2.36. The thresholds are as follows: Strongly Undervalued below -8.02, Undervalued between -8.02 and -5.19, Fairly Valued between 0.48 and -5.19, Overvalued between 0.48 and 3.31, and Strongly Overvalued above 3.31. The current Forward P/FCF of -0.63 falls within the Historic Trend Line -Fairly Valued range.

Purple Biotech Ltd (PPBT) has a current Price-to-Book (P/B) ratio of 20.73. Compared to its 3-year average P/B ratio of 76.05 , the current P/B ratio is approximately -72.74% higher. Relative to its 5-year average P/B ratio of 122.20, the current P/B ratio is about -83.04% higher. Purple Biotech Ltd (PPBT) has a Forward Free Cash Flow (FCF) yield of approximately -87.81%. Compared to its 3-year average FCF yield of -121.68%, the current FCF yield is approximately -27.84% lower. Relative to its 5-year average FCF yield of -81.44% , the current FCF yield is about 7.81% lower.

20.73

P/B

Median3y

76.05

Median5y

122.20

-87.81

FCF Yield

Median3y

-121.68

Median5y

-81.44

Competitors Valuation Multiple

The average P/S ratio for PPBT's competitors is 0.00, providing a benchmark for relative valuation. Purple Biotech Ltd Corp (PPBT) exhibits a P/S ratio of 0.00, which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of PPBT increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of PPBT in the past 1 year is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is Purple Biotech Ltd (PPBT) currently overvalued or undervalued?

What is Purple Biotech Ltd (PPBT) fair value?

PPBT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Purple Biotech Ltd (PPBT) is between to according to relative valuation methord.

How does PPBT's valuation metrics compare to the industry average?

What is the current P/B ratio for Purple Biotech Ltd (PPBT) as of Dec 16 2025?

As of Dec 16 2025, Purple Biotech Ltd (PPBT) has a P/B ratio of 20.73. This indicates that the market values PPBT at 20.73 times its book value.

What is the current FCF Yield for Purple Biotech Ltd (PPBT) as of Dec 16 2025?

As of Dec 16 2025, Purple Biotech Ltd (PPBT) has a FCF Yield of -87.81%. This means that for every dollar of Purple Biotech Ltd’s market capitalization, the company generates -87.81 cents in free cash flow.

What is the current Forward P/E ratio for Purple Biotech Ltd (PPBT) as of Dec 16 2025?

As of Dec 16 2025, Purple Biotech Ltd (PPBT) has a Forward P/E ratio of -0.44. This means the market is willing to pay $-0.44 for every dollar of Purple Biotech Ltd’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Purple Biotech Ltd (PPBT) as of Dec 16 2025?

As of Dec 16 2025, Purple Biotech Ltd (PPBT) has a Forward P/S ratio of 0.00. This means the market is valuing PPBT at $0.00 for every dollar of expected revenue over the next 12 months.

PPBT Valuation

PPBT Valuation

PPBT Relative Valuation

Historical Valuation

Competitors Valuation Multiple

Performance Decomposition

People Also Watch

Frequently Asked Questions

Is Purple Biotech Ltd (PPBT) currently overvalued or undervalued?

What is Purple Biotech Ltd (PPBT) fair value?

How does PPBT's valuation metrics compare to the industry average?

What is the current P/B ratio for Purple Biotech Ltd (PPBT) as of Dec 16 2025?

What is the current FCF Yield for Purple Biotech Ltd (PPBT) as of Dec 16 2025?

What is the current Forward P/E ratio for Purple Biotech Ltd (PPBT) as of Dec 16 2025?

What is the current Forward P/S ratio for Purple Biotech Ltd (PPBT) as of Dec 16 2025?